Changing epidemiology of dengue in Sri Lanka-Challenges for the future.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
08 2021
08 2021
Historique:
entrez:
19
8
2021
pubmed:
20
8
2021
medline:
17
11
2021
Statut:
epublish
Résumé
Dengue infections are on the rise in Sri Lanka and are spreading to all areas in the country. Here, we discuss the changes in dengue epidemiology in Sri Lanka in relation to changes in age distribution, changes in seroprevalence rates over time, and possible reasons contributing to such changes. Although the incidence of dengue increased 20-fold from the year 2000 to 2012 and a further 3-fold from 2012 to 2019, this increase is not reflected in a similar increase in the age-stratified seropositivity rates for dengue. For instance, the annual seroconversion rates were 0.76% in 2013 and 0.91% in 2017. The annual seroconversion rates in the 6 to 17 age group were 1.5% per year in 2003, 3.9% in 2013, and 4.1% in 2017. In addition, although a 13-fold increase in dengue was seen in those who were <19 years of age, a 52.4-fold increase was seen in the 40- to 59-year age group. The case fatality rates (CFRs) have similarly changed, with 61.8% of deaths occurring in those <19 years of age in the year 2000, while in 2012 to 2018, the highest CFR were seen in those who were aged 20 to 39 years. Although there has been a marked increase in the number of cases, the vector densities did not change during a 4-year period. The proportion of adult individuals experiencing a secondary dengue infection has also remained between 65% and 75% between the years 2004 and 2018. A change in the ratio of symptomatic to asymptomatic infections can give rise to changes in the reported incidence of dengue. In order to take an appropriate policy decision in dengue control activities, it would be important to study the changes in virus serotypes, vector dispersion, and densities. Further, the contribution of the rise in metabolic diseases to an increase in the symptomatic as well as more severe infections due to dengue is explored.
Sections du résumé
BACKGROUND
Dengue infections are on the rise in Sri Lanka and are spreading to all areas in the country. Here, we discuss the changes in dengue epidemiology in Sri Lanka in relation to changes in age distribution, changes in seroprevalence rates over time, and possible reasons contributing to such changes.
METHODS AND FINDINGS
Although the incidence of dengue increased 20-fold from the year 2000 to 2012 and a further 3-fold from 2012 to 2019, this increase is not reflected in a similar increase in the age-stratified seropositivity rates for dengue. For instance, the annual seroconversion rates were 0.76% in 2013 and 0.91% in 2017. The annual seroconversion rates in the 6 to 17 age group were 1.5% per year in 2003, 3.9% in 2013, and 4.1% in 2017. In addition, although a 13-fold increase in dengue was seen in those who were <19 years of age, a 52.4-fold increase was seen in the 40- to 59-year age group. The case fatality rates (CFRs) have similarly changed, with 61.8% of deaths occurring in those <19 years of age in the year 2000, while in 2012 to 2018, the highest CFR were seen in those who were aged 20 to 39 years. Although there has been a marked increase in the number of cases, the vector densities did not change during a 4-year period. The proportion of adult individuals experiencing a secondary dengue infection has also remained between 65% and 75% between the years 2004 and 2018.
CONCLUSIONS
A change in the ratio of symptomatic to asymptomatic infections can give rise to changes in the reported incidence of dengue. In order to take an appropriate policy decision in dengue control activities, it would be important to study the changes in virus serotypes, vector dispersion, and densities. Further, the contribution of the rise in metabolic diseases to an increase in the symptomatic as well as more severe infections due to dengue is explored.
Identifiants
pubmed: 34411101
doi: 10.1371/journal.pntd.0009624
pii: PNTD-D-20-00898
pmc: PMC8375976
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0009624Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Microbiol Immunol Infect. 2020 Feb;53(1):69-78
pubmed: 30146413
Diabet Med. 2008 Sep;25(9):1062-9
pubmed: 19183311
Sci Rep. 2018 Mar 1;8(1):3857
pubmed: 29497121
Emerg Infect Dis. 2009 Jan;15(1):8-11
pubmed: 19116042
J Infect Dis. 2011 May 1;203(9):1292-300
pubmed: 21335562
Br Heart J. 1972 Aug;34(8):821-7
pubmed: 4262698
N Engl J Med. 2005 Sep 1;353(9):924-32
pubmed: 16135837
PLoS Negl Trop Dis. 2016 Feb 24;10(2):e0004466
pubmed: 26910907
WHO South East Asia J Public Health. 2014 Jan-Mar;3(1):5-7
pubmed: 28607248
PLoS Negl Trop Dis. 2016 Feb 29;10(2):e0004477
pubmed: 26927901
PLoS One. 2018 Jul 17;13(7):e0200698
pubmed: 30016369
Arch Virol. 2013 Jul;158(7):1445-59
pubmed: 23471635
Ceylon Med J. 1967 Jun;12(2):67-74
pubmed: 5588663
PLoS One. 2015 Dec 22;10(12):e0144799
pubmed: 26696417
Emerg Infect Dis. 2009 Feb;15(2):192-9
pubmed: 19193262
PLoS Negl Trop Dis. 2010 Jun 01;4(6):e699
pubmed: 20532230
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Clinics (Sao Paulo). 2016 Aug;71(8):455-63
pubmed: 27626476
Trop Med Int Health. 2004 Sep;9(9):1022-9
pubmed: 15361117
Am J Trop Med Hyg. 2014 Jul;91(1):132-7
pubmed: 24865684
Am J Trop Med Hyg. 1988 Jan;38(1):172-80
pubmed: 3341519
BMC Res Notes. 2012 Nov 20;5:645
pubmed: 23167997
Ceylon Med J. 1966 Dec;11(4):129-42
pubmed: 5984948
Lancet Infect Dis. 2016 Aug;16(8):935-41
pubmed: 27091092
Trop Med Int Health. 2006 Jun;11(6):935-42
pubmed: 16772016
Emerg Infect Dis. 2011 Nov;17(11):2053-5
pubmed: 22099096
PLoS One. 2012;7(11):e50387
pubmed: 23209731
Int J Infect Dis. 2019 Nov;88:88-99
pubmed: 31521850
QJM. 2006 May;99(5):299-305
pubmed: 16603571
Front Immunol. 2014 Jun 11;5:280
pubmed: 24966859
Emerg Infect Dis. 2020 Apr;26(4):682-691
pubmed: 32186490
PLoS Negl Trop Dis. 2018 Oct 1;12(10):e0006540
pubmed: 30273352
Sci Rep. 2017 Jan 03;7:39872
pubmed: 28045096